Society of Thoracic Surgeons Appoints New CEO
The Society of Thoracic Surgeons (STS) appointed Justine Varieur Turco as its CEO and executive director, effective August 31, 2026.
The Society of Thoracic Surgeons (STS) appointed Justine Varieur Turco as its CEO and executive director, effective August 31, 2026.
The MATCH 2 study reported a 96.7% overall diagnostic yield for peripheral lung nodules when using robotic-assisted bronchoscopy (RAB) with integrated imaging.
A new five-step anesthesia protocol increased the likelihood of positive dreams, which may help reduce patient fear and improve emotional recovery after surgery.
Data from clinical trials investigating treatments for pulmonary hypertension and pulmonary fibrosis will be highlighted at ATS 2026.
A study of more than 32,000 CTPA scans found that artificial intelligence and physicians agreed on pulmonary embolism results nearly 98% of the time, though human review caught cases the software missed.
Implementing specific protocols for older surgical patients can reduce complications such as delirium, falls, and pneumonia.
Researchers have developed a new form of CRISPR technology that destroys harmful cells instead of editing their genes, while leaving healthy tissue untouched.